ASLAN Pharmaceuticals and BioGenetics Co Ltd, a leading South Korean healthcare company, today announced that they have expanded their strategic collaboration by entering into a new commercialisation agreement whereby both parties will partner to commercialise ASLAN003 in all indications in South Korea.
For more information, please refer to the English or Chinese press release.